LSTA
Price:
$3.56
Market Cap:
$32.42M
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, t...[Read more]
Industry
Biotechnology
IPO Date
1999-03-01
Stock Exchange
NASDAQ
Ticker
LSTA
According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.23. This represents a change of -17.42% compared to the average of 5.12 of the last 4 quarters.
The mean historical Current Ratio of Lisata Therapeutics, Inc. over the last ten years is 8.27. The current 4.23 Current Ratio has changed 5.01% with respect to the historical average. Over the past ten years (40 quarters), LSTA's Current Ratio was at its highest in in the March 2022 quarter at 32.38. The Current Ratio was at its lowest in in the March 2017 quarter at 0.94.
Average
8.27
Median
7.21
Minimum
1.26
Maximum
21.27
Discovering the peaks and valleys of Lisata Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 419.13%
Maximum Annual Current Ratio = 21.27
Minimum Annual Increase = -47.05%
Minimum Annual Current Ratio = 1.26
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.76 | -6.42% |
| 2024 | 6.16 | -24.72% |
| 2023 | 8.18 | -27.33% |
| 2022 | 11.26 | -47.05% |
| 2021 | 21.27 | 111.02% |
| 2020 | 10.08 | 131.87% |
| 2019 | 4.35 | -44.63% |
| 2018 | 7.85 | 19.63% |
| 2017 | 6.56 | 419.13% |
| 2016 | 1.26 | -9.26% |
The current Current Ratio of Lisata Therapeutics, Inc. (LSTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.70
5-year avg
10.53
10-year avg
8.27
Lisata Therapeutics, Inc.’s Current Ratio is greater than MetaVia Inc. (2.73), less than NuCana plc (5.48), less than Enlivex Therapeutics Ltd. (193.24), greater than Passage Bio, Inc. (1.73), greater than Exicure, Inc. (0.79), greater than CASI Pharmaceuticals, Inc. (0.30), greater than Clearside Biomedical, Inc. (2.98), greater than Pelthos Therapeutics Inc. (2.76), less than Klotho Neurosciences, Inc. (95.01), greater than CollPlant Biotechnologies Ltd. (2.27),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.73 | $3.83M | |
| 5.48 | $11.84M | |
| 193.24 | $16.29M | |
| 1.73 | $18.64M | |
| 0.79 | $17.72M | |
| 0.30 | $2.33M | |
| 2.98 | $2.15M | |
| 2.76 | $17.83M | |
| 95.01 | $20.08M | |
| 2.27 | $4.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lisata Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Lisata Therapeutics, Inc. (LSTA)?
What is the highest Current Ratio for Lisata Therapeutics, Inc. (LSTA)?
What is the 3-year average Current Ratio for Lisata Therapeutics, Inc. (LSTA)?
What is the 5-year average Current Ratio for Lisata Therapeutics, Inc. (LSTA)?
How does the current Current Ratio for Lisata Therapeutics, Inc. (LSTA) compare to its historical average?